Newsletter - All News

Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research

Category

Continent

From

To

Spinogenix Secures INN Approval for Tazbentetol —...

Spinogenix Secures INN Approval for Tazbentetol —...

Category : Approval/Launch 2 December 2025

Spinogenix just scored a major milestone. The WHO’s INN Expert Committee has officially approv...

Cytiva and Veeda Lifesciences Launch HCP Services...

Cytiva and Veeda Lifesciences Launch HCP Services...

Category : Licensing/Collaboration Deal 1 December 2025

Cytiva, a Danaher company and global life sciences leader, has partnered with Veeda Lifesciences to...

Ascletis Selects ASC37 as Its First Oral Triple Ag...

Ascletis Selects ASC37 as Its First Oral Triple Ag...

Category : Clinical Trial Update 1 December 2025

Ascletis Pharma has taken a major step in its metabolic disease pipeline by selecting ASC37 oral tab...

Innovent’s Mazdutide 9 mg Moves One Step Closer to...

Innovent’s Mazdutide 9 mg Moves One Step Closer to...

Category : Clinical Trial Update 28 November 2025

China may soon have a powerful new option for treating moderate to severe obesity. Innovent Biologi...

Chugai’s Port Delivery System Hits Key Milestone i...

Chugai’s Port Delivery System Hits Key Milestone i...

Category : Clinical Trial Update 28 November 2025

A New Long-Term Treatment Option for nAMD and DME Patients Chugai Pharmaceutical has reported res...

‹
1
2

Subscribe to Our Newsletter!

Subscribe to get latest updates and information.